Pharos iBio파로스아이바이오
388870 · KOSDAQ · ₩388870 · 파로스아이바이오
₩5,890▲ ₩80 (1.38%)End-of-day · Oct 28, 2026 · End-of-day prices.
Filings
- Half-year report (Jun 2026)반기보고서 (2026.06)Aug 13, 2026Open on DART
- Adjustment of Conversion Price (1st Series)전환가액의조정 (제1회차)Jul 20, 2026Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Jun 4, 2026Open on DART
- Other management matters기타경영사항(자율공시) ([국책과제 선정] 보건복지부 주관 2026년도 구조기반 AI 신약개발지원 사업 협약 체결)Jun 1, 2026Open on DART
- Quarterly report (Mar 2026)분기보고서 (2026.03)May 14, 2026Open on DART
- Investor relations (IR) event기업설명회(IR)개최Apr 13, 2026Open on DART
- Change of Head Office Location본점소재지변경Mar 27, 2026Open on DART
- Annual general meeting results정기주주총회결과Mar 27, 2026Open on DART
- Report on Appointment, Dismissal, or Mid-Term Resignation of Independent Directors독립이사의선임ㆍ해임또는중도퇴임에관한신고Mar 27, 2026Open on DART
- Annual report (Dec 2025)사업보고서 (2025.12)Mar 19, 2026Open on DART
- Audit report submitted감사보고서제출Mar 18, 2026Open on DART
- Notice of shareholders' meeting주주총회소집공고Mar 11, 2026Open on DART
- Notice of Reason for Concentrated Shareholders' Meeting Date주주총회집중일개최사유신고Mar 6, 2026Open on DART
- Amended: Shareholders' meeting called[기재정정]주주총회소집결의Mar 6, 2026Open on DART
- [Amended] Notice of Stock Purchase Option Grant[기재정정]주식매수선택권부여에관한신고Feb 11, 2026Open on DART
- Shareholders' meeting called주주총회소집결의Feb 10, 2026Open on DART
- [Amended] Notice of Stock Purchase Option Grant[기재정정]주식매수선택권부여에관한신고Feb 10, 2026Open on DART
- [Amended] Notice of Stock Purchase Option Grant[기재정정]주식매수선택권부여에관한신고Feb 10, 2026Open on DART
- 5%+ holding report주식등의대량보유상황보고서(일반)Jan 16, 2026Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Jan 16, 2026Open on DART
- 5%+ holding report주식등의대량보유상황보고서(약식)Jan 9, 2026Open on DART
- Results of Securities Issuance (Voluntary Disclosure) (1st Convertible Bonds)증권발행결과(자율공시) (제1회차 CB)Dec 19, 2025Open on DART
- Determination of Shareholder Register Closure Period or Record Date주주명부폐쇄기간또는기준일설정Dec 12, 2025Open on DART
- Convertible bond issue decision주요사항보고서(전환사채권발행결정)Dec 3, 2025Open on DART
- Quarterly report (Sep 2025)분기보고서 (2025.09)Nov 11, 2025Open on DART
- Half-year report (Jun 2025)반기보고서 (2025.06)Aug 13, 2025Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Jul 21, 2025Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Jul 16, 2025Open on DART
- Major management matter relevant to investors투자판단관련주요경영사항(임상시험결과) (경구용 항암제 PHI101의 임상 1상 임상시험결과보고서(CSR) 수령)Jun 30, 2025Open on DART
- Amended: Major management matter relevant to investors[기재정정]투자판단관련주요경영사항(임상시험계획승인신청등결정) (BRAF, KRAS 또는 NRAS 돌연변이를 가진 진행성 고형암 환자를 대상으로 PHI501의 안전성, 내약성, 약동/약력학 및 예비 임상 활성을 평가하기 위한 제1상 임상시험계획(IND) 승인)Jun 26, 2025Open on DART
- Major management matter relevant to investors투자판단관련주요경영사항(임상시험계획승인신청등결정) (BRAF, KRAS 또는 NRAS 돌연변이를 가진 진행성 고형암 환자를 대상으로 PHI501의 안전성, 내약성, 약동/약력학 및 예비 임상 활성을 평가하기 위한 제1상 임상시험계획(IND) 승인)Jun 25, 2025Open on DART
- Quarterly report (Mar 2025)분기보고서 (2025.03)May 15, 2025Open on DART
- Annual general meeting results정기주주총회결과Mar 25, 2025Open on DART
- Notice on Grant of Stock Purchase Options주식매수선택권부여에관한신고Mar 25, 2025Open on DART
- Annual report (Dec 2024)사업보고서 (2024.12)Mar 18, 2025Open on DART
- Audit report submitted감사보고서제출Mar 17, 2025Open on DART
- Notice of shareholders' meeting주주총회소집공고Mar 7, 2025Open on DART
- Major management matter relevant to investors투자판단관련주요경영사항(임상시험계획승인신청) (BRAF, KRAS 또는 NRAS 돌연변이를 가진 진행성 고형암 환자를 대상으로 PHI501의 제1상 임상시험계획승인신청(IND))Mar 5, 2025Open on DART
- Shareholders' meeting called주주총회소집결의Feb 10, 2025Open on DART
- [Amended] Notice of Stock Purchase Option Grant[기재정정]주식매수선택권부여에관한신고Dec 20, 2024Open on DART
- Determination of Shareholder Register Closure Period or Record Date주주명부폐쇄기간또는기준일설정Dec 16, 2024Open on DART
- Quarterly report (Sep 2024)분기보고서 (2024.09)Nov 14, 2024Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Sep 30, 2024Open on DART
- Half-year report (Jun 2024)반기보고서 (2024.06)Aug 14, 2024Open on DART
- Notice on Grant of Stock Purchase Options주식매수선택권부여에관한신고Jul 19, 2024Open on DART
- Amended: Quarterly report (Mar 2024)[기재정정]분기보고서 (2024.03)May 17, 2024Open on DART
- Quarterly report (Mar 2024)분기보고서 (2024.03)May 16, 2024Open on DART
- Annual general meeting results정기주주총회결과Mar 28, 2024Open on DART
- Notice on Grant of Stock Purchase Options주식매수선택권부여에관한신고Mar 28, 2024Open on DART
- Audit report submitted감사보고서제출Mar 20, 2024Open on DART
Titles in Korean until English translations are added.
Also known as: Pharos iBio / 파로스아이바이오 / 388870 / KRX:388870
Source: KRX statistical information